Parkinson’s disease is a progressive neurodegenerative disease that worsens with time. With a primary focus on Parkinson’s disease, research at the PPRC is aimed at slowing or halting the progression of the disease and improving quality of life. 

For more information on research at the PPRC and Djavad Mowafaghian Centre for Brain Health, please visit the research section of the PPRC website, or email the research coordinators at

Centre for Applied Neurogenetics (CAN)

With a focus on genetic analysis of typical, late-onset Parkinson’s disease, the CAN team discovers genetic factors that enhance disease susceptibility. Main research methods include clinical studies, multimodal neuroimaging, and molecular neurogenetics.